Ghent University Academic Bibliography

Your filters: cql: author="Willekens, Barbara" or (type any "bookEditor issueEditor" and editor="Willekens, Barbara")

Add to list
- Journal Article
- A1
- open access
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN) : study protocol for a multi-center randomized placebo controlled clinical trial

Anna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, Lander Willem, Melissa Cambron (UGent) , Guy Laureys (UGent) , Miguel D’ Haeseleer, Maria Bjerke, Ella Roelant, Marc Lemmerling, et al.

(2024) FRONTIERS IN IMMUNOLOGY. 15.
Add to list
Multiple sclerosis multidisciplinary care : a national survey and lessons for the global community

Liesbeth Van Hijfte (UGent) , Melissa Cambron (UGent) , Brigitte Capron, Bernard Dachy, Danny Decoo, Dominique Dive, Bénédicte Dubois, Souraya El Sankari, Frederic London, Gaetano Perrotta, et al.

(2024) MULTIPLE SCLEROSIS AND RELATED DISORDERS. 85.
Add to list
- Journal Article
- A1
- open access
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia Joseph Khoury, Tunde Csepany, Barbara Willekens, et al.

(2024) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.
Add to list
- Journal Article
- A1
- open access
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, et al.

(2024) THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 17.
Add to list
- Journal Article
- A1
- open access
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Suzanne Hodgkinson, Raed Alroughani, Sara Eichau Madueño, Cavit Boz, Anneke van der Walt, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL. 30(9). p.1163-1175
Add to list
Routine CSF parameters as predictors of disease course in multiple sclerosis : an MSBase cohort study

Cathérine Dekeyser (UGent) , Matthias Hautekeete, Melissa Cambron, Vincent Van Pesch, Francesco Patti, Jens Kuhle, Samia Khoury, Jeanette Lechner Scott, Oliver Gerlach, Alessandra Lugaresi, et al.

(2024) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 95(11). p.1021-1031
Add to list
- Journal Article
- A1
- open access
Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

Wei Z. Yeh, Anneke Van Der Walt, Olga G. Skibina, Tomas Kalincik, Raed Alroughani, Allan G. Kermode, Marzena J. Fabis-Pedrini, William M. Carroll, Jeannette Lechner-Scott, Cavit Boz, et al.

(2024) NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 11(6).
Add to list
- Journal Article
- A1
- open access
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B. Malpas, Sifat Sharmin, Cavit Boz, Raed Alroughani, Serkan Ozakbas, Katherine Buzzard, Olga Skibina, et al.

(2023) JAMA NEUROLOGY. 80(8). p.789-797
Add to list
- Journal Article
- A1
- open access
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina M Sánchez, Serkan Ozakbas, Dana Horakova, Eva K Havrdova, Francesco Patti, Raed Alroughani, et al.

(2023) BRAIN. 146(11). p.4633-4644
Add to list
- Journal Article
- A1
- open access
Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Tomas Kalincik, Sifat Sharmin, Izanne Roos, Mark S. Freedman, Harold Atkins, Joachim Burman, Jennifer Massey, Ian Sutton, Barbara Withers, Richard Macdonell, et al.

(2023) JAMA NEUROLOGY. 80(7). p.702-713

Academic Bibliography

A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN) : study protocol for a multi-center randomized placebo controlled clinical trial

Multiple sclerosis multidisciplinary care : a national survey and lessons for the global community

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Routine CSF parameters as predictors of disease course in multiple sclerosis : an MSBase cohort study

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Contents

Support

Contact